Literature DB >> 14748560

Microglial activation parallels system degeneration in multiple system atrophy.

Keisuke Ishizawa1, Takashi Komori, Shoichi Sasaki, Nobutaka Arai, Toshio Mizutani, Takanori Hirose.   

Abstract

Multiple system atrophy (MSA) is a neurodegenerative disorder that predominantly affects motor-related neuroanatomic structures. The role of microglia in MSA is unknown. To address this issue, we conducted quantitative image studies on the brains from 13 cases of MSA, comprising 8 cerebellar and 5 parkinsonian variants. Microglial and glial cytoplasmic inclusion (GCI) burdens were determined with image analysis on brain sections immunostained with antibodies to HLA-DR and alpha-synuclein. Many activated microglia, as well as GCIs, were noted in motor-related structures, including the cerebellar input, extrapyramidal motor, and pyramidal motor structures, but not in the cerebellar output structures. This result indicates that microglial activation, as well as the distribution of GCIs, is system-specific in MSA. The correlation analysis between the microglial and GCI burdens yielded variable yet significant correlations in the cerebellar input, extrapyramidal motor, and pyramidal motor systems, but not in the cerebellar output system. This result suggests that microglial activation is at least partly determined by GCIs or oligodendroglial alpha-synuclein in specific neuroanatomic systems affected in MSA. Taken together, considering the known toxic effects of microglia in neurodegenerative diseases, microglia may play a part in the development of system-specific tissue injuries, contributing to the system-bound clinical and pathological phenotypes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14748560     DOI: 10.1093/jnen/63.1.43

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  62 in total

1.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

2.  Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter.

Authors:  James D Mills; Jieqiong Chen; Woojin S Kim; Paul D Waters; Avanita S Prabowo; Eleonora Aronica; Glenda M Halliday; Michael Janitz
Journal:  Neurogenetics       Date:  2015-03-29       Impact factor: 2.660

Review 3.  Treatment of multiple system atrophy - the past, present and future.

Authors:  Haiyan Yu; Xiaoling Yuan; Lifeng Liu; Tian Wang; Dianrong Gong
Journal:  Am J Clin Exp Immunol       Date:  2018-10-05

Review 4.  Novel therapeutic approaches in multiple system atrophy.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2014-06-14       Impact factor: 4.435

Review 5.  The neuropathology of multiple system atrophy and its therapeutic implications.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Auton Neurosci       Date:  2017-11-10       Impact factor: 3.145

6.  Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy.

Authors:  Elvira Valera; Kiren Ubhi; Michael Mante; Edward Rockenstein; Eliezer Masliah
Journal:  Glia       Date:  2013-12-06       Impact factor: 7.452

7.  Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein.

Authors:  Arianna Bellucci; Andrew J Westwood; Esther Ingram; Fiorella Casamenti; Michel Goedert; Maria Grazia Spillantini
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

8.  Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.

Authors:  Nadia Stefanova; Markus Reindl; Manuela Neumann; Christian Haass; Werner Poewe; Philipp J Kahle; Gregor K Wenning
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 9.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

10.  Involvement of 4-hydroxy-2-nonenal accumulation in multiple system atrophy.

Authors:  Noriyuki Shibata; Yuri Inose; Sono Toi; Atsuko Hiroi; Tomoko Yamamoto; Makio Kobayashi
Journal:  Acta Histochem Cytochem       Date:  2010-04-21       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.